|
|
my account
log out
|
Anti-TACSTD2 (clone 7E6)-AcLys-VC-PABC-0101 |
| Create: 04/27/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone 7E6) conjugated via a AcLys-VC-PABC linker to a drug. Due to its carcinogenic nature and cell surface localization, TACSTD2 has been exploited as a target for ADC-based immunotherapies. It is the target for antibody-drug conjugates such as sacituzumab govitecan, an ADC that bears SN38, a topoisomerase I inhibitor, for accurate cancer elimination.https://www.creative-biolabs.com/adc/target-tacstd2-93.htm |
![]() | |
| City: | Shirley[US]
|
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 270 | |
| Feb 01 2023 | GVBE Buffer | 278 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 278 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 273 | |
| Aug 30 2019 | Anti-HSV-2 gH Antibody | 463 | |
| Aug 30 2019 | Anti-L. major LPG Antibody | 545 | |
| Aug 30 2019 | Anti-DENV-1 Antibody | 453 | |
| Aug 30 2019 | Anti-BPV-1 L1 Antibody | 467 | |
| Aug 30 2019 | Anti-H3N2 HA Antibody | 455 | |
| Aug 30 2019 | Anti-EIAV env Antibody | 476 |
| Copyright © toextrade Inc. All rights reserved. Contact us |